Skip to content
prognosis

Moderna Says Dosing Started in Pediatric Study of Covid Shot

By
Updated on
  • About 6,750 children expected to be enrolled in U.S., Canada.
  • Study to test two dose levels in older kids, three in younger
AstraZeneca Shot Speculation 'Not Helpful': Moderna Co-founder

Moderna Inc. said the first children have been dosed in a clinical trial of its Covid-19 vaccine in kids from six months to less than 12 years old.

The phase 2-phase 3 trial is being conducted in conjunction with the National Institute of Allergy and Infectious Diseases, the company said in a statement on Tuesday. The study is expected to enroll approximately 6,750 participants in the U.S. and Canada.